ACCP - ACCP Medicare Coverage Initiative

E-mail:

Password: Forgot your password?

OR

Become a Member

If you would like to become a member of ACCP, join today.

Create a Free Account

If you have never logged into ACCP.com before, create a free account.

[govt_medicareASPX_lblPageTitle]

ACCP Medication Optimization Initiatives

[govt_medicareASPX_divPageContent]

ACCP has established a comprehensive set of initiatives that will pursue policy and payment reform to recognize the direct patient care services of qualified clinical pharmacists, for example, legislative and regulatory changes to the Medicare program and relevant sections of the Social Security Act (Section 1861) for comprehensive medication management (CMM), to be a covered benefit under Medicare.

To learn more about these important initiatives, please review the resources below. Click the title to view.

2022

November 2022: ACCP Urges Group of Physicians Serving in Congress to Include Clinical Pharmacists in Mediare Value-Based Care Teams.
May 2022: ACCP Urges House Energy and Commerce Committee to Advance Pharmacogenomic Consultations by Qualified Clinical Pharmacists.
April 2022: ACCP Leads Pharmacy Voice among Multi-Stakeholder Public Health Advocates Calling for Public Health Infrastructure Investment: Centers for Disease Control Coalition (CDC): Invest in protecting the public’s health from COVID-19, chronic disease prevention, combating the opioid, tobacco, e-cigarette and obesity epidemics, and emergency preparedness Friends of National Center for Health Statistics (NCHS): Invest in the future of US health statistics Friends of Agency for Healthcare Research and Quality (AHRQ): Invest in research to improve health care quality, reduce costs, advance patient safety, decrease medical errors, and broaden access to essential services Friends of Title V Maternal and Child Health Programs Block Grant: Invest in reducing maternal and infant mortality, and preventable diseases among children; advancing health equity and eliminating racial, ethnic, and geographic inequities in maternal and child health outcomes.
March 2022: ACCP Comments to Senate Finance Committee in response to hearing - Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare

2021

August 2021: ACCP Comments to PCORI on Proposed National Priorities for Health
March 2021: ACCP Joins National Pharmacy Organizations Welcoming Secretary Becerra
February 2021: ACCP Endorses Xavier Becerra for HHS Secretary

2020

October 2020: ACCP Comments to House Appropriations Applauding Efforts to Expand Innovative Medicare Comprehensive Medication Management (CMM) Models
September 2020: Joint Pharmacy Statement Supporting Utilization of Pharmacists in Administration of the COVID-19 Vaccine
August 2020: ACCP Comments to House Energy & Commerce Committee Related to Treatment for Substance Abuse Disorders During the COVID Crisis
September 2020: Statement from leaders of 12 US pharmacy organizations celebrating the U.S. Department of Human Services order that expands the role of pharmacists in providing vaccines to children
July 2020: ACCP Comments to HHS related to Authorization for Licensed Pharmacists to Order and Administer COVID-19 Vaccine
June 2020: ACCP Comments to HELP Committee in Response Hearings on the COVID-19 Pandemic
May 2020: ACCP Joins Professional Pharmacy Organizations Urging Rep. Maloney (D-NY) to Incldue Pharmacists in Student Loan Forgiveness Legislation
April 2020: ACCP Comments to CMS Statement in Response to the Request for Information Regarding Maternal and Infant Health Care in Rural Communities

2019

December 2019: ACCP Statement to the House Energy and Commerce Committee in response to a "Call to Action" soliciting feedback on the development of Cures 2.0 legislation
October 2019: ACCP Statement to the Center for Medicare and Medicaid Services (CMS) in Response to the Request for Information (RFI) for the Development of a CMS Action Plan to Prevent Opioid Addiction and Enhance Access to Medication-Assisted Treatment
May 2019: ACCP Statement to the House Energy and Commerce Committee on Prescription Drug Coverage in the Medicare Program
April 2019: ACCP Comments to HHS on Best Practices from the Pain Management Best Practices Inter-Agency Task Force: Updates, Gaps, Inconsistencies, and Recommendations
March 2019: ACCP Statement to the Senate Committee on Health, Education, Labor and Pensions (HELP): Recommendations to Address America's Rising Health Care Costs

2018

May 2018 – ACCP Statement congratulating Adam Boehler on his appointment as Director of the Centers for Medicare and Medicaid Innovation.
February 2018 – ACCP Opioid Epidemic Statement 2018

2017

November 2017 – ACCP Statement to the Center for Medicare and Medicaid Services (CMS) in Response to the Request for Information (RFI) Related to a New Direction for the CMS Innovation Center
May 2017 – ACCP Comments Senate Committee on Finance, "Examining Bipartisan Medicare Policies that Improve Care for Patients with Chronic Conditions"
March 2017 – News Update: ACCP Testifies Before House Committee on Appropriations
March 2017 – ACCP Testimony to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies Hearing for Outside Witnesses

2016

December 2016 – ACCP Comments to CMS related to Final Rule implementing the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
December 2016 – ACCP Letter Congratulating President-Elect Trump on his Election Victory
December 2016 - ACCP Letter Congratulating Congressman Erik Paulsen on his Election Victory
ACCP Letter of Congratulations to Rep. Welch
June 2016 – ACCP Comments to CMS related to the implementation of the core Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) provisions of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
June 2016 – ACCP Congressional Briefing Slides - "Getting the Medications Right": An essential ingredient in achieving the goals of H.R. 4878 – the Medicare Better Care, Lower Cost Act
May 2016 – ACCP Congressional Briefing Announcement - "Getting the Medications Right": An essential ingredient in achieving the goals of H.R. 4878 – the Medicare Better Care, Lower Cost Act
March 2016 – ACCP letter to Representatives Erik Paulsen & Peter Welch endorsing the reintroduction of the"Better Care, Lower Cost Act."

2015

December 2015 – ACCP Comments to CMS in Response to Request for Information Regarding Pharmacist Labor Cost Association with Direct Practice Expense Calculations.
October 2015 – ACCP& CPNP Comments to the House Energy & Commerce Committee related to a hearing entitled: "Examining the Medicare Part D Medication Therapy Management Program"
June 2015 – ACCP Comments to Senate Finance Committee Bipartisan Working Group Examining Solutions to Improve Outcomes for Medicare Patients Requiring Chronic Care.
June 2015 – ACCP comments in response to Senate Finance Committee hearing: "A Pathway to Improving Care for Medicare Patients with Chronic Conditions."
January 2015 – ACCP comments in response to House Energy & Commerce Committee hearing: "A Permanent Solution to the SGR: The Time is Now."

2014

July 2014 – ACCP Responds to Senate Finance Committee request for input from health care stakeholders on ideas that will enhance the availability and utility of health care data.
July 2014 – ACCP Comments on Senate Finance Committee hearing: "Chronic Illness: Addressing Patients' Unmet Needs."
June 2014 - Washington Report: Medicare Initiative Update.
March 2014 - Special Washington Report: The PAPCC, H.R. 4190, and ACCP A group of pharmacy associations, chain drug stores, and other interested stakeholders launched a coalition, the Patient Access to Pharmacists' Care Coalition (PAPCC), to advance Medicare Part B "provider status" for pharmacists.
March 2014 – ACCP & CPNP Endorse the Better Care, Lower Cost Act (Similar letters were sent to the other original co-sponsors in the Senate and House)
February 2014 – Medicare Initiative Update. Part B Comprehensive Medication Management Coverage vs. "Provider Status": Examining the Difference

2013

December 2013 – Medicare Initiative Update: 2013 Review
June 2013 – ACCP Comments on House Energy & Commerce Committee hearing entitled "A 21st Century Medicare: Bipartisan Proposals to Redesign the Program's Outdated Benefit Structure."
June 2013 – ACCP Comments to the House Energy and Commerce Committee on the draft legislation, "Reforming the Sustainable Growth Rate (SGR) and Medicare Payments for Physician Services."
June 2013 – ACCP Report - ACCP's Medicare Initiative Advocacy Resources Are Now Available
April 2013 – ACCP Press Release – ACCP and CPNP to Partner On Medicare Coverage Initiative
March 2013 - ACCP Report - President's Column - We Meant What We Said … But Let's Be Clear About What We Said.
March 2013 – ACCP Board Commentary - Qualifications of Pharmacists Who Provide Direct Patient Care: Perspectives on the Need for Residency Training and Board Certification
March 2013 - ACCP Advocacy Overview – Medicare Coverage Initiative for Direct Patient Care Services of Qualified Clinical Pharmacists
January 2013 - ACCP Report - ACCP Moves Forward with Medicare Benefit Initiative to Recognize Clinical Pharmacists' Direct Patient Care Services
January 2013 - ACCP Report - President's Column - Seeking a Change in the Medicare Benefit—What it Means to ACCP
January 2013 - Press Release - The Federal Group to Represent Clinical Pharmacy Association

2012

December 2012 - ACCP Report – ACCP Launches New Initiative to Seek Provider Status for Clinical Pharmacists Working in All Practice Settings
February 2012 - ACCP Report – Washington Report - Coverage for Clinical Pharmacy Services in Medicare: Understanding the Legislative Process

Advancing Our Medicare Initiative through Grassroots Action

Without the active participation of ACCP members in the advocacy process, our Medicare initiative cannot succeed. With more than 13,000 members, ACCP has the potential to exert considerable influence on Capitol Hill. But to realize this potential we need the active participation of all our members as grassroots advocates.

ACCP's Step-By-Step Guide to Hosting a Visit of Elected Officials to Your Practice Setting

Hosting a visit of your elected officials to your practice is perhaps the single most important thing you can do to help lawmakers understand what team-based, patient centered clinical practice is all about – and to generate their support for recognition and payment for clinical pharmacists' services.

A comprehensive guide to inviting a member of Congress to tour your practice site is available on our Legislative Action Center. If you would like to discuss the process of hosting a lawmaker at your practice site, please contact John McGlew at (202) 621-1820 or jmcglew@accp.com.

Support Your Profession, Support Your PAC

A well-funded Political Action Committee (PAC) will demonstrate the support within the profession for our legislative initiative and the importance ACCP members attach to moving it forward in Congress.

There are numerous PACs representing various segments of the pharmacy profession, but only ACCP-PAC is dedicated to advancing the practice of clinical pharmacy.

If each ACCP member contributes just $25, ACCP-PAC would raise $300,000. All ACCP members should consider making a donation of at least $25 to ACCP-PAC.

CLICK HERE to support your PAC today!

Contact ACCP's Washington, DC Office

1455 Pennsylvania Ave., NW, Suite 400
Washington, DC 20004-1017
202.621.1820
202.621.1819 [fax]

John K. McGlew
Director, Government Affairs
jmcglew@accp.com